Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Barry Uretsky

Concepts (614)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Percutaneous Coronary Intervention
97
2024
328
21.390
 Why?
Coronary Occlusion
58
2023
80
12.370
 Why?
Coronary Artery Disease
41
2024
323
11.950
 Why?
Fractional Flow Reserve, Myocardial
39
2023
127
11.130
 Why?
Angioplasty, Balloon, Coronary
48
2020
168
10.090
 Why?
Stents
50
2023
368
7.980
 Why?
Coronary Angiography
96
2023
367
7.720
 Why?
Coronary Vessels
32
2024
169
7.210
 Why?
Coronary Stenosis
22
2021
98
6.040
 Why?
Myocardial Infarction
46
2024
449
4.740
 Why?
Drug-Eluting Stents
22
2023
101
4.730
 Why?
Treatment Outcome
120
2024
5508
4.400
 Why?
Cardiac Catheterization
19
2023
228
3.720
 Why?
Coronary Artery Bypass
17
2022
135
2.790
 Why?
Acute Coronary Syndrome
8
2022
106
2.700
 Why?
Humans
228
2024
52441
2.530
 Why?
Chronic Disease
52
2023
579
2.290
 Why?
Tomography, Optical Coherence
8
2018
110
2.210
 Why?
Saphenous Vein
12
2021
63
2.060
 Why?
Graft Occlusion, Vascular
13
2021
78
2.030
 Why?
Risk Factors
65
2023
3971
1.950
 Why?
Platelet Aggregation Inhibitors
11
2014
211
1.950
 Why?
Coronary Thrombosis
8
2020
22
1.860
 Why?
Myocardial Ischemia
11
2020
130
1.690
 Why?
Registries
32
2023
638
1.660
 Why?
Male
120
2024
26874
1.650
 Why?
Thrombosis
11
2018
250
1.640
 Why?
Predictive Value of Tests
23
2023
938
1.620
 Why?
Cardiology
13
2019
105
1.610
 Why?
Coronary Restenosis
8
2021
39
1.610
 Why?
Myocardium
17
2013
471
1.520
 Why?
Heptanoic Acids
15
2008
35
1.470
 Why?
Aged
70
2023
10242
1.470
 Why?
Pyrroles
15
2008
73
1.430
 Why?
Time Factors
39
2023
2987
1.420
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
13
2022
148
1.360
 Why?
Heart Injuries
3
2019
16
1.300
 Why?
Middle Aged
78
2024
13133
1.300
 Why?
Risk Assessment
26
2023
1349
1.280
 Why?
Myocardial Reperfusion Injury
10
2011
53
1.170
 Why?
Cardiac Tamponade
2
2024
27
1.120
 Why?
Collateral Circulation
10
2020
38
1.090
 Why?
Female
80
2024
28277
1.080
 Why?
Vasodilator Agents
5
2016
90
1.010
 Why?
Coronary Circulation
9
2024
57
0.980
 Why?
Heart Failure
13
2019
527
0.970
 Why?
Heart-Assist Devices
3
2020
155
0.960
 Why?
Contrast Media
8
2018
173
0.930
 Why?
Prosthesis Design
11
2021
262
0.920
 Why?
Cardiac Catheters
4
2020
12
0.910
 Why?
Ventricular Dysfunction, Left
7
2018
107
0.910
 Why?
Societies, Medical
9
2019
200
0.910
 Why?
Thrombolytic Therapy
2
2020
113
0.910
 Why?
Pericarditis
2
2022
20
0.870
 Why?
Balloon Occlusion
1
2024
17
0.840
 Why?
Ventricular Function, Left
11
2023
174
0.840
 Why?
Adenosine
7
2018
75
0.840
 Why?
Pericardial Effusion
1
2024
39
0.830
 Why?
Coronary Disease
6
2015
145
0.810
 Why?
Hemorrhage
4
2019
225
0.810
 Why?
Cardiovascular Agents
5
2009
65
0.790
 Why?
Occupational Health
1
2023
66
0.780
 Why?
Aneurysm, False
5
2020
42
0.780
 Why?
Postoperative Complications
10
2019
1065
0.780
 Why?
Pericarditis, Constrictive
1
2022
2
0.770
 Why?
Aorta
3
2019
170
0.730
 Why?
Hypotension, Controlled
1
2021
3
0.730
 Why?
Radiography, Interventional
7
2018
58
0.720
 Why?
Anemia
1
2022
75
0.710
 Why?
Retrospective Studies
27
2020
6694
0.710
 Why?
Thrombocytopenia
1
2022
93
0.690
 Why?
Mammary Arteries
3
2017
10
0.690
 Why?
Absorbable Implants
2
2022
13
0.690
 Why?
Inferior Wall Myocardial Infarction
1
2020
1
0.670
 Why?
Thiazolidinediones
6
2008
81
0.660
 Why?
Time-to-Treatment
2
2020
77
0.650
 Why?
Shock, Cardiogenic
1
2020
35
0.640
 Why?
Prognosis
16
2023
2100
0.640
 Why?
Algorithms
4
2021
673
0.640
 Why?
Cardiovascular Diseases
11
2015
493
0.630
 Why?
Digitalis
1
2019
4
0.620
 Why?
Diabetic Angiopathies
2
2013
24
0.620
 Why?
Enbucrilate
1
2019
6
0.620
 Why?
Tissue Adhesives
1
2019
15
0.620
 Why?
Arterial Pressure
1
2019
46
0.620
 Why?
Hyperemia
3
2016
17
0.610
 Why?
Pericardium
4
2022
32
0.610
 Why?
Operative Time
3
2019
76
0.600
 Why?
Guideline Adherence
1
2020
142
0.600
 Why?
Practice Guidelines as Topic
2
2020
498
0.580
 Why?
Aspirin
5
2022
122
0.570
 Why?
Hematoma
2
2013
67
0.570
 Why?
Hydrostatic Pressure
1
2017
7
0.550
 Why?
Follow-Up Studies
16
2019
2294
0.540
 Why?
Angioplasty, Balloon
4
2022
68
0.530
 Why?
Death, Sudden, Cardiac
2
2008
55
0.530
 Why?
Perioperative Care
5
2015
43
0.530
 Why?
Heart Septum
2
2010
21
0.530
 Why?
Creatine Kinase, MB Form
3
2013
10
0.530
 Why?
Adrenergic beta-Antagonists
3
2008
107
0.530
 Why?
Surgical Procedures, Operative
4
2015
66
0.510
 Why?
Foramen Ovale, Patent
2
2014
31
0.510
 Why?
Purinergic P2Y Receptor Antagonists
2
2014
34
0.500
 Why?
Heart Ventricles
4
2012
259
0.490
 Why?
Veterans
1
2022
573
0.480
 Why?
United States
25
2022
5215
0.480
 Why?
Propranolol
2
2008
76
0.480
 Why?
Electrocardiography
10
2022
273
0.480
 Why?
Prospective Studies
14
2023
2433
0.470
 Why?
Severity of Illness Index
13
2019
1045
0.470
 Why?
Alloys
2
2020
9
0.470
 Why?
Fibrinolytic Agents
3
2014
131
0.450
 Why?
Aortic Valve
3
2022
130
0.450
 Why?
Tomography, X-Ray Computed
5
2013
1140
0.450
 Why?
Vascular System Injuries
1
2015
39
0.440
 Why?
Wounds, Penetrating
1
2015
40
0.440
 Why?
Randomized Controlled Trials as Topic
10
2015
625
0.440
 Why?
Ultrasonography, Interventional
7
2013
137
0.430
 Why?
Purines
2
2014
34
0.430
 Why?
Cardiotonic Agents
7
2019
70
0.430
 Why?
Adenosine A2 Receptor Agonists
1
2014
5
0.430
 Why?
Stroke Volume
7
2023
148
0.430
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
3
2009
46
0.420
 Why?
Physician-Patient Relations
1
2015
142
0.420
 Why?
Anterior Wall Myocardial Infarction
2
2012
7
0.420
 Why?
Computer-Assisted Instruction
1
2014
30
0.420
 Why?
Metals
2
2011
37
0.410
 Why?
Cyclooxygenase 2
8
2008
47
0.410
 Why?
Piperazines
2
2012
125
0.410
 Why?
Blood Vessel Prosthesis Implantation
4
2009
122
0.410
 Why?
Anticholesteremic Agents
3
2008
31
0.410
 Why?
Troponin T
2
2011
13
0.410
 Why?
Mentors
1
2014
55
0.400
 Why?
Pyrazoles
2
2014
116
0.400
 Why?
Arteries
1
2013
93
0.400
 Why?
Atrial Function, Left
1
2013
5
0.400
 Why?
Endarterectomy, Carotid
2
2011
60
0.400
 Why?
Lipoxins
3
2008
3
0.400
 Why?
Incidence
12
2018
1096
0.400
 Why?
Cardiac Surgical Procedures
3
2014
329
0.390
 Why?
Tissue Donors
1
2013
126
0.380
 Why?
Rats, Sprague-Dawley
14
2008
1558
0.380
 Why?
Physicians
2
2015
237
0.380
 Why?
Drug Eruptions
1
2012
14
0.380
 Why?
Rats
19
2011
3228
0.380
 Why?
Thiophenes
1
2012
45
0.370
 Why?
Stroke
3
2013
527
0.370
 Why?
Drug Administration Schedule
5
2014
370
0.370
 Why?
Quality Assurance, Health Care
4
2012
147
0.360
 Why?
Embolism
2
2013
18
0.360
 Why?
Cyclooxygenase Inhibitors
5
2007
39
0.360
 Why?
Internet
1
2014
262
0.360
 Why?
Diverticulum
1
2011
21
0.350
 Why?
Troponin I
1
2011
19
0.350
 Why?
Transurethral Resection of Prostate
1
2011
10
0.350
 Why?
Intraoperative Complications
4
2020
113
0.350
 Why?
Carotid Arteries
1
2011
77
0.350
 Why?
Clinical Trials as Topic
4
2012
461
0.340
 Why?
Pressure
3
2017
100
0.340
 Why?
Receptors, Adrenergic, beta-2
2
2009
16
0.340
 Why?
Embolic Protection Devices
1
2010
7
0.340
 Why?
Myocytes, Cardiac
5
2011
146
0.340
 Why?
Receptors, Opioid, delta
2
2009
25
0.340
 Why?
Clinical Competence
4
2013
405
0.340
 Why?
Paclitaxel
1
2011
91
0.340
 Why?
Heart
5
2006
352
0.330
 Why?
Pericardiectomy
2
2024
6
0.330
 Why?
Mitral Valve
1
2010
57
0.320
 Why?
Endocarditis
1
2010
31
0.320
 Why?
Kaplan-Meier Estimate
6
2017
485
0.320
 Why?
Digoxin
3
2019
21
0.320
 Why?
Echocardiography, Transesophageal
2
2006
60
0.300
 Why?
Sirolimus
2
2009
72
0.300
 Why?
Anticoagulants
5
2024
276
0.300
 Why?
Carotid Artery, Common
2
2006
44
0.290
 Why?
Hypoglycemic Agents
3
2006
223
0.290
 Why?
Tissue Plasminogen Activator
1
2009
108
0.290
 Why?
Myocardial Bridging
1
2008
2
0.290
 Why?
Heart Failure, Systolic
1
2008
7
0.290
 Why?
Suction
1
2008
22
0.290
 Why?
Azetidines
1
2008
6
0.280
 Why?
Peptides
2
2008
239
0.280
 Why?
Heart Valve Prosthesis
2
2022
89
0.280
 Why?
Aortic Valve Stenosis
2
2022
79
0.280
 Why?
Patient Selection
7
2012
269
0.280
 Why?
Consensus
2
2007
195
0.280
 Why?
Telemedicine
1
2014
490
0.270
 Why?
Heart Septal Defects, Atrial
2
2013
45
0.270
 Why?
Vascular Patency
5
2020
82
0.260
 Why?
Hemodynamics
7
2018
235
0.260
 Why?
Laboratories, Hospital
1
2006
6
0.260
 Why?
Coronary Aneurysm
1
2007
18
0.260
 Why?
Defibrillators, Implantable
2
2007
63
0.260
 Why?
Terminology as Topic
3
2013
69
0.250
 Why?
Animals
25
2022
13485
0.250
 Why?
Echocardiography, Three-Dimensional
1
2006
15
0.250
 Why?
Chi-Square Distribution
3
2017
292
0.250
 Why?
Pacemaker, Artificial
1
2007
41
0.250
 Why?
Angina, Unstable
3
2016
25
0.240
 Why?
Mitral Valve Insufficiency
2
2007
56
0.240
 Why?
Bacteremia
1
2007
87
0.240
 Why?
Inpatients
2
2018
203
0.240
 Why?
Gadolinium DTPA
1
2005
26
0.240
 Why?
Kidney Failure, Chronic
2
2004
205
0.230
 Why?
Nitric Oxide Synthase Type III
6
2008
83
0.230
 Why?
Lipopolysaccharides
1
2006
205
0.230
 Why?
Carotid Artery Diseases
1
2005
32
0.230
 Why?
Angina, Stable
2
2016
7
0.230
 Why?
Calcium
1
2007
396
0.230
 Why?
Proportional Hazards Models
6
2017
446
0.230
 Why?
Prostaglandins
1
2005
21
0.230
 Why?
Neovascularization, Physiologic
2
2005
86
0.230
 Why?
Program Evaluation
1
2006
351
0.230
 Why?
Renal Insufficiency
1
2005
109
0.220
 Why?
Pain Management
3
2015
187
0.220
 Why?
Chemokine CCL2
1
2004
65
0.220
 Why?
Plasminogen Activator Inhibitor 1
1
2004
7
0.220
 Why?
Europe
6
2019
90
0.220
 Why?
History, 21st Century
2
2019
60
0.210
 Why?
Pericardiocentesis
1
2024
16
0.210
 Why?
Monocytes
1
2004
124
0.210
 Why?
Equipment Design
3
2020
287
0.210
 Why?
History, 20th Century
2
2019
100
0.210
 Why?
Reoperation
5
2013
463
0.210
 Why?
Staphylococcal Infections
1
2007
270
0.210
 Why?
Secondary Prevention
2
2015
85
0.210
 Why?
Reproducibility of Results
6
2016
1223
0.210
 Why?
Heart Rupture, Post-Infarction
1
2003
3
0.210
 Why?
Cardiomyopathy, Hypertrophic
1
2004
34
0.210
 Why?
Nitric Oxide Synthase Type II
4
2008
62
0.200
 Why?
Disease Models, Animal
9
2011
1483
0.200
 Why?
Adult
14
2019
14205
0.200
 Why?
Double-Blind Method
5
2020
726
0.200
 Why?
Calcinosis
1
2023
48
0.200
 Why?
Materials Testing
2
2020
55
0.190
 Why?
Dose-Response Relationship, Drug
8
2017
1365
0.190
 Why?
American Heart Association
4
2015
44
0.190
 Why?
Hospital Mortality
5
2019
451
0.190
 Why?
Femoral Artery
2
2019
104
0.190
 Why?
Coronary Vessel Anomalies
2
2017
37
0.190
 Why?
Recurrence
7
2016
680
0.180
 Why?
Angiography
3
2012
111
0.170
 Why?
Retreatment
2
2012
58
0.170
 Why?
Drug Therapy, Combination
5
2008
404
0.170
 Why?
Vasodilation
1
2021
99
0.170
 Why?
Up-Regulation
4
2011
462
0.170
 Why?
United States Department of Veterans Affairs
1
2022
291
0.160
 Why?
Heart Valve Prosthesis Implantation
2
2016
103
0.160
 Why?
Ischemia
1
2021
150
0.160
 Why?
Angioplasty
1
2020
21
0.160
 Why?
Calcitonin Gene-Related Peptide
2
2009
24
0.160
 Why?
Risk
3
2011
315
0.160
 Why?
6-Ketoprostaglandin F1 alpha
3
2008
4
0.160
 Why?
Plaque, Atherosclerotic
1
2019
43
0.150
 Why?
Logistic Models
3
2018
930
0.150
 Why?
Specialization
1
2019
48
0.150
 Why?
Atherectomy
1
2019
13
0.150
 Why?
Cost-Benefit Analysis
2
2014
271
0.150
 Why?
Russia
4
2019
10
0.150
 Why?
Propanolamines
2
2011
13
0.150
 Why?
Quality Improvement
2
2011
226
0.150
 Why?
Radial Artery
1
2019
34
0.150
 Why?
Catheterization
1
2019
94
0.150
 Why?
Peripheral Arterial Disease
1
2019
78
0.150
 Why?
Survival Analysis
5
2010
656
0.150
 Why?
Odds Ratio
3
2016
563
0.150
 Why?
Proto-Oncogene Proteins c-akt
3
2009
168
0.150
 Why?
Catheterization, Peripheral
1
2019
49
0.150
 Why?
Patient Care Planning
1
2019
68
0.140
 Why?
Feasibility Studies
1
2020
404
0.140
 Why?
Aged, 80 and over
5
2017
3449
0.140
 Why?
Patient Safety
1
2018
102
0.140
 Why?
Emergency Medical Services
1
2019
123
0.140
 Why?
Diabetes Mellitus, Type 2
1
2004
570
0.140
 Why?
Medicare
2
2011
281
0.140
 Why?
Education, Medical
1
2019
112
0.130
 Why?
Constriction, Pathologic
1
2017
89
0.130
 Why?
Adventitia
1
2017
3
0.130
 Why?
Education, Medical, Graduate
3
2013
217
0.130
 Why?
Curriculum
3
2013
406
0.130
 Why?
Hospitalization
3
2011
731
0.130
 Why?
Advisory Committees
2
2014
74
0.130
 Why?
Cardiac Pacing, Artificial
2
2008
33
0.130
 Why?
Prevalence
4
2018
1016
0.130
 Why?
Phosphorylation
6
2008
536
0.130
 Why?
Nitric Oxide Synthase
2
2008
72
0.130
 Why?
Simvastatin
2
2008
27
0.120
 Why?
Propensity Score
1
2017
160
0.120
 Why?
Aortic Valve Insufficiency
1
2016
25
0.120
 Why?
Administration, Oral
5
2015
455
0.120
 Why?
Benzazepines
2
2006
20
0.120
 Why?
Magnetic Resonance Imaging
1
2022
1507
0.120
 Why?
Renal Insufficiency, Chronic
1
2018
198
0.120
 Why?
Postpericardiotomy Syndrome
1
2015
4
0.110
 Why?
Diagnostic Techniques, Cardiovascular
2
2012
3
0.110
 Why?
Colchicine
1
2015
24
0.110
 Why?
Angina Pectoris
2
2020
19
0.110
 Why?
Smad3 Protein
1
2014
9
0.110
 Why?
Cholesterol, Dietary
1
2014
19
0.110
 Why?
Th2 Cells
1
2014
21
0.110
 Why?
Cyclic AMP-Dependent Protein Kinases
3
2011
50
0.110
 Why?
Patient Care Management
1
2014
18
0.110
 Why?
Venous Thrombosis
1
2015
89
0.110
 Why?
Area Under Curve
3
2022
182
0.110
 Why?
Receptors, LDL
1
2014
73
0.110
 Why?
Health Care Costs
1
1995
176
0.110
 Why?
Cardiovascular System
1
2014
55
0.110
 Why?
Thromboembolism
1
2014
48
0.110
 Why?
Atherosclerosis
2
2014
224
0.110
 Why?
Dependovirus
1
2014
104
0.100
 Why?
Transfection
1
2014
365
0.100
 Why?
Remote Consultation
1
2014
29
0.100
 Why?
Drug Costs
1
2014
40
0.100
 Why?
Quality Indicators, Health Care
2
2011
91
0.100
 Why?
Arrhythmias, Cardiac
2
2012
97
0.100
 Why?
Cardiac Output, Low
2
2006
10
0.100
 Why?
Septal Occluder Device
1
2013
36
0.100
 Why?
Echocardiography, Doppler, Color
1
2013
21
0.100
 Why?
Pulmonary Edema
1
2013
15
0.100
 Why?
Echocardiography, Doppler
2
2016
56
0.100
 Why?
Signal Transduction
3
2009
1724
0.100
 Why?
General Surgery
1
2014
106
0.100
 Why?
Cohort Studies
5
2022
1576
0.100
 Why?
Heparin
2
2024
88
0.100
 Why?
Evidence-Based Medicine
2
2011
271
0.100
 Why?
Pleural Effusion
1
2013
38
0.100
 Why?
Case-Control Studies
2
2013
1202
0.100
 Why?
Image Processing, Computer-Assisted
1
2014
234
0.090
 Why?
Kidney Diseases
2
2007
230
0.090
 Why?
Heart Transplantation
3
2009
320
0.090
 Why?
Embolism, Cholesterol
1
2011
2
0.090
 Why?
Multivariate Analysis
4
2016
601
0.090
 Why?
Myocardial Revascularization
2
2012
29
0.090
 Why?
Hypertrophy, Left Ventricular
2
2009
41
0.090
 Why?
Age Factors
3
2021
1120
0.090
 Why?
Cardiovascular Surgical Procedures
2
2012
12
0.090
 Why?
Ultrasonography
2
2010
416
0.090
 Why?
Milrinone
1
2011
7
0.090
 Why?
Treatment Failure
2
2018
117
0.090
 Why?
Insurance Claim Review
1
2011
41
0.090
 Why?
Enkephalin, D-Penicillamine (2,5)-
2
2009
3
0.090
 Why?
Equipment Failure
2
2008
63
0.090
 Why?
Unnecessary Procedures
1
2011
20
0.090
 Why?
Punctures
2
2019
50
0.090
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2011
73
0.080
 Why?
Thrombectomy
1
2011
74
0.080
 Why?
Cyclooxygenase 2 Inhibitors
2
2007
20
0.080
 Why?
Necrosis
1
2010
169
0.080
 Why?
Injections, Intra-Arterial
2
2015
13
0.080
 Why?
Disease Management
3
2014
185
0.080
 Why?
Cells, Cultured
4
2009
1583
0.080
 Why?
Surgical Instruments
1
2010
29
0.080
 Why?
Systole
1
2010
71
0.080
 Why?
Magnetic Resonance Imaging, Cine
1
2010
64
0.080
 Why?
Reperfusion Injury
2
2007
73
0.080
 Why?
Endothelium, Vascular
3
2007
263
0.080
 Why?
Receptors, Calcitonin Gene-Related Peptide
1
2009
4
0.080
 Why?
Phosphodiesterase Inhibitors
2
2007
22
0.080
 Why?
Myocardial Contraction
2
2009
109
0.080
 Why?
ROC Curve
2
2022
249
0.080
 Why?
Hyperlipidemias
2
2011
52
0.070
 Why?
Drug Administration Routes
1
2008
10
0.070
 Why?
Leukotriene B4
1
2008
1
0.070
 Why?
Arachidonate 5-Lipoxygenase
1
2008
3
0.070
 Why?
Fatal Outcome
2
2007
193
0.070
 Why?
Survival Rate
3
2018
944
0.070
 Why?
Hemostasis, Surgical
1
2008
12
0.070
 Why?
Phospholipases A
2
2006
14
0.070
 Why?
Phospholipases A2
2
2006
15
0.070
 Why?
Diabetes Complications
2
2011
124
0.070
 Why?
Patient Transfer
1
2009
99
0.070
 Why?
Comorbidity
1
2010
637
0.070
 Why?
Meta-Analysis as Topic
1
2008
39
0.070
 Why?
Drainage
1
2008
88
0.070
 Why?
Sulfonamides
2
2008
137
0.070
 Why?
Myocardial Reperfusion
1
2007
13
0.070
 Why?
Combined Modality Therapy
1
2009
641
0.070
 Why?
Mitogen-Activated Protein Kinase 3
1
2007
47
0.070
 Why?
Tetrazoles
1
2007
41
0.070
 Why?
Dipyridamole
1
2007
8
0.070
 Why?
Prosthesis Failure
2
2012
112
0.070
 Why?
Microinjections
2
2018
35
0.070
 Why?
Prostaglandin D2
1
2007
21
0.070
 Why?
Cyclooxygenase 1
1
2007
7
0.070
 Why?
Waiting Lists
1
2007
53
0.070
 Why?
Sex Factors
2
2022
735
0.070
 Why?
Analysis of Variance
1
2008
558
0.070
 Why?
Disease Progression
2
2008
870
0.070
 Why?
Nitroso Compounds
1
2006
3
0.060
 Why?
Calcium Signaling
1
2007
57
0.060
 Why?
Patient Admission
1
2007
80
0.060
 Why?
Thoracic Surgery
1
2007
22
0.060
 Why?
Enzyme Induction
1
2006
78
0.060
 Why?
PPAR gamma
1
2007
72
0.060
 Why?
Biotin
1
2006
46
0.060
 Why?
Chest Pain
1
2006
55
0.060
 Why?
Ubiquinone
1
2006
14
0.060
 Why?
NF-kappa B
1
2008
326
0.060
 Why?
Drug Interactions
1
2007
198
0.060
 Why?
Acute Disease
3
2019
384
0.060
 Why?
Hemofiltration
1
2006
8
0.060
 Why?
Diagnosis, Differential
2
2012
1028
0.060
 Why?
Magnesium
1
2006
35
0.060
 Why?
Forecasting
1
2007
151
0.060
 Why?
Electric Countershock
1
2006
30
0.060
 Why?
Preoperative Care
1
2007
173
0.060
 Why?
Intracranial Embolism
1
2006
29
0.060
 Why?
Radiology
1
2008
132
0.060
 Why?
Heart Atria
1
2006
62
0.060
 Why?
Ischemic Preconditioning
1
2005
5
0.060
 Why?
Texas
2
2006
137
0.060
 Why?
Aortic Rupture
1
2006
18
0.060
 Why?
Triiodobenzoic Acids
1
2005
9
0.060
 Why?
Partnership Practice
1
2005
1
0.060
 Why?
Organizational Affiliation
1
2005
2
0.060
 Why?
Myocardial Stunning
1
2005
2
0.060
 Why?
Health Planning
1
2005
13
0.060
 Why?
Carbazoles
1
2005
18
0.060
 Why?
Pyrrolidines
1
2006
65
0.060
 Why?
Metoprolol
1
2005
13
0.060
 Why?
Foreign Bodies
1
2006
66
0.060
 Why?
Device Removal
1
2006
83
0.060
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2006
123
0.060
 Why?
Gastrointestinal Hemorrhage
1
2006
91
0.060
 Why?
Aortic Coarctation
1
2006
31
0.060
 Why?
Accidents, Traffic
1
2006
91
0.060
 Why?
Arginine Vasopressin
1
2005
7
0.060
 Why?
Isoxazoles
1
2005
15
0.060
 Why?
Intramolecular Oxidoreductases
1
2005
11
0.060
 Why?
Prostaglandin-Endoperoxide Synthases
1
2005
25
0.060
 Why?
Tetralogy of Fallot
1
2006
83
0.060
 Why?
Education, Medical, Continuing
1
2005
76
0.060
 Why?
Ephedrine
1
2004
21
0.060
 Why?
Regional Blood Flow
1
2004
109
0.060
 Why?
Leadership
1
2005
105
0.060
 Why?
Hyperhomocysteinemia
1
2004
29
0.060
 Why?
Membrane Proteins
1
2007
344
0.050
 Why?
Polyethylene Terephthalates
1
2004
10
0.050
 Why?
Brachiocephalic Trunk
1
2004
6
0.050
 Why?
Antioxidants
1
2006
255
0.050
 Why?
Ventricular Remodeling
1
2004
65
0.050
 Why?
Abnormalities, Multiple
1
2006
164
0.050
 Why?
Vascular Endothelial Growth Factor A
1
2005
186
0.050
 Why?
Creatinine
1
2004
156
0.050
 Why?
Pregnancy Complications, Cardiovascular
1
2004
38
0.050
 Why?
Arteriosclerosis
1
2004
49
0.050
 Why?
Random Allocation
1
2005
286
0.050
 Why?
Swine Diseases
1
2004
7
0.050
 Why?
Hypertension
2
2011
560
0.050
 Why?
Potassium Channels
1
2004
31
0.050
 Why?
Enoxaparin
1
2024
31
0.050
 Why?
ATP-Binding Cassette Transporters
1
2004
35
0.050
 Why?
Inflammation
2
2007
649
0.050
 Why?
Cytochrome P-450 Enzyme System
1
2005
191
0.050
 Why?
Staphylococcus aureus
1
2007
312
0.050
 Why?
Atrial Fibrillation
1
2006
196
0.050
 Why?
Vasoconstrictor Agents
1
2004
81
0.050
 Why?
Heart Diseases
1
2006
217
0.050
 Why?
Glomerular Filtration Rate
2
2018
126
0.050
 Why?
Creatine Kinase
1
2003
31
0.050
 Why?
Sample Size
1
2003
50
0.050
 Why?
Isoenzymes
1
2003
171
0.050
 Why?
Health Policy
2
2012
162
0.050
 Why?
Retroperitoneal Space
1
2002
25
0.050
 Why?
Internship and Residency
1
2008
438
0.050
 Why?
Death
1
2022
22
0.050
 Why?
C-Reactive Protein
1
2003
151
0.050
 Why?
Quality of Life
1
2008
893
0.050
 Why?
Immunohistochemistry
1
2005
977
0.050
 Why?
Cardiomyopathies
1
2003
117
0.050
 Why?
Drug Synergism
3
2007
147
0.050
 Why?
Morphine Derivatives
1
2022
27
0.050
 Why?
Renal Dialysis
1
2003
189
0.050
 Why?
Anesthesia
1
2002
67
0.050
 Why?
Mass Screening
1
2004
354
0.040
 Why?
Epoprostenol
1
2001
12
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2001
48
0.040
 Why?
Hospitals
1
2022
182
0.040
 Why?
Pulmonary Wedge Pressure
1
2001
18
0.040
 Why?
Benchmarking
2
2011
64
0.040
 Why?
Kidney
1
2005
716
0.040
 Why?
Heart Arrest
1
2002
145
0.040
 Why?
Arkansas
2
2016
2013
0.040
 Why?
Tissue Scaffolds
1
2020
40
0.040
 Why?
Biocompatible Materials
1
2020
67
0.040
 Why?
Public Policy
2
2012
38
0.040
 Why?
Antihypertensive Agents
1
2001
129
0.040
 Why?
Anti-Inflammatory Agents
2
2015
166
0.040
 Why?
Graft Rejection
2
2009
166
0.040
 Why?
Oxidative Stress
1
2004
805
0.040
 Why?
Risk Adjustment
1
2019
17
0.040
 Why?
Mice, Knockout
2
2014
903
0.040
 Why?
Injections, Intralesional
1
2018
32
0.040
 Why?
Internationality
1
2018
46
0.040
 Why?
Radiation Dosage
1
2019
160
0.040
 Why?
Administration, Intravenous
1
2018
73
0.030
 Why?
Immunoblotting
2
2008
118
0.030
 Why?
Radiation Monitoring
1
2017
7
0.030
 Why?
International Cooperation
2
2007
52
0.030
 Why?
Sex Characteristics
1
1999
210
0.030
 Why?
Enzyme-Linked Immunosorbent Assay
2
2008
234
0.030
 Why?
Interferon-alpha
1
1996
52
0.030
 Why?
Mice
3
2014
5899
0.030
 Why?
Italy
1
2015
27
0.030
 Why?
Blood Flow Velocity
1
2015
97
0.030
 Why?
Phlebography
1
2015
54
0.030
 Why?
Cost Savings
1
1995
60
0.030
 Why?
Tubulin Modulators
1
2015
28
0.030
 Why?
Monte Carlo Method
1
1995
89
0.030
 Why?
Cross-Sectional Studies
1
2020
1677
0.030
 Why?
Decision Support Techniques
1
1995
73
0.030
 Why?
Cause of Death
2
2007
157
0.030
 Why?
Syndrome
2
2006
247
0.030
 Why?
Time
1
2014
29
0.030
 Why?
Journal Impact Factor
1
2014
9
0.030
 Why?
Liver Transplantation
1
1996
171
0.030
 Why?
Genetic Vectors
1
2014
128
0.030
 Why?
Models, Cardiovascular
2
2004
22
0.030
 Why?
Fibrosis
1
2014
198
0.030
 Why?
Monitoring, Physiologic
1
2014
122
0.030
 Why?
Learning Curve
1
2013
20
0.030
 Why?
Apoptosis
2
2011
1120
0.030
 Why?
Ischemic Attack, Transient
1
2013
60
0.030
 Why?
Cardiac Imaging Techniques
1
2012
8
0.020
 Why?
Gene Expression Regulation
2
2008
1004
0.020
 Why?
Mice, Inbred C57BL
2
2008
1888
0.020
 Why?
Tissue Survival
1
2012
10
0.020
 Why?
Myocardial Perfusion Imaging
1
2012
17
0.020
 Why?
Exercise Test
2
2002
134
0.020
 Why?
Tomography, Emission-Computed, Single-Photon
1
2012
50
0.020
 Why?
Phosphodiesterase 3 Inhibitors
1
2011
1
0.020
 Why?
Adrenergic beta-1 Receptor Antagonists
1
2011
7
0.020
 Why?
In Situ Nick-End Labeling
1
2011
54
0.020
 Why?
Echocardiography
2
2005
409
0.020
 Why?
Diagnostic Imaging
1
2012
171
0.020
 Why?
Recovery of Function
1
2012
201
0.020
 Why?
Infusions, Intravenous
1
2011
212
0.020
 Why?
Critical Care
1
2012
213
0.020
 Why?
Lymphocytes
1
1991
146
0.020
 Why?
Program Development
1
2011
164
0.020
 Why?
Data Collection
1
2011
285
0.020
 Why?
Adrenergic beta-2 Receptor Antagonists
1
2009
1
0.020
 Why?
Adrenergic beta-2 Receptor Agonists
1
2009
4
0.020
 Why?
Transplantation, Homologous
1
2009
151
0.020
 Why?
Cell Death
1
2009
169
0.020
 Why?
Isoquinolines
1
2008
21
0.020
 Why?
Serine
1
2008
37
0.020
 Why?
Tyrphostins
1
2008
10
0.020
 Why?
Janus Kinases
1
2008
8
0.020
 Why?
Electrophoretic Mobility Shift Assay
1
2008
71
0.020
 Why?
Selection Bias
1
2008
15
0.020
 Why?
Ischemic Preconditioning, Myocardial
1
2007
2
0.020
 Why?
Enzyme Activation
1
2008
269
0.020
 Why?
Organ Culture Techniques
1
2007
47
0.020
 Why?
Creatine Kinase, BB Form
1
2007
1
0.020
 Why?
Immunologic Factors
1
2008
114
0.020
 Why?
Receptors, Purinergic P1
1
2007
8
0.020
 Why?
Survival
1
2007
13
0.020
 Why?
Theophylline
1
2007
20
0.020
 Why?
5'-Nucleotidase
1
2007
12
0.020
 Why?
Nitriles
1
2007
51
0.020
 Why?
Smoking
1
2011
514
0.020
 Why?
Blood Coagulation
1
2007
64
0.020
 Why?
Models, Chemical
1
2007
65
0.020
 Why?
Premedication
1
2007
18
0.020
 Why?
Butadienes
1
2007
49
0.020
 Why?
Drug Combinations
1
2007
136
0.020
 Why?
Coenzymes
1
2006
3
0.020
 Why?
Oncogene Protein v-akt
1
2006
11
0.020
 Why?
Fluid Therapy
1
2007
80
0.020
 Why?
Educational Measurement
1
2008
196
0.020
 Why?
Receptors, Vasopressin
1
2006
23
0.020
 Why?
Phosphoric Monoester Hydrolases
1
2006
23
0.020
 Why?
Alanine
1
2006
43
0.020
 Why?
Amidines
1
2006
8
0.020
 Why?
Benzylamines
1
2006
15
0.020
 Why?
Protein Kinase Inhibitors
1
2008
231
0.020
 Why?
Sulfones
1
2006
24
0.020
 Why?
PTEN Phosphohydrolase
1
2006
55
0.020
 Why?
Models, Animal
1
2006
230
0.010
 Why?
Research Design
1
2008
368
0.010
 Why?
Nitric Oxide
1
2007
238
0.010
 Why?
Magnetic Resonance Angiography
1
2006
67
0.010
 Why?
Heart Conduction System
1
2005
24
0.010
 Why?
Body Weight
1
2007
524
0.010
 Why?
Safety
1
2005
78
0.010
 Why?
Enzyme Inhibitors
1
2007
378
0.010
 Why?
Nitroglycerin
1
2004
6
0.010
 Why?
Multicenter Studies as Topic
1
2005
112
0.010
 Why?
Radiography
1
2006
469
0.010
 Why?
Injections, Intravenous
1
2004
130
0.010
 Why?
Aortography
1
2004
33
0.010
 Why?
Sensitivity and Specificity
1
2006
871
0.010
 Why?
Glyburide
1
2004
6
0.010
 Why?
Anastomosis, Surgical
1
2004
69
0.010
 Why?
Health Personnel
1
2007
255
0.010
 Why?
Anesthesia, Obstetrical
1
2004
40
0.010
 Why?
Ventricular Fibrillation
1
2004
18
0.010
 Why?
Models, Biological
1
2007
735
0.010
 Why?
Vascular Surgical Procedures
1
2006
166
0.010
 Why?
Patient Discharge
1
2006
320
0.010
 Why?
Statistics as Topic
1
2004
89
0.010
 Why?
Transcription Factors
1
2007
570
0.010
 Why?
Tachycardia, Ventricular
1
2004
45
0.010
 Why?
Anti-Arrhythmia Agents
1
2004
79
0.010
 Why?
NG-Nitroarginine Methyl Ester
1
2003
15
0.010
 Why?
Cesarean Section
1
2004
182
0.010
 Why?
Swine
1
2004
428
0.010
 Why?
Endpoint Determination
1
2002
27
0.010
 Why?
Brain
1
2006
1337
0.010
 Why?
Pregnancy
1
2004
2642
0.010
 Why?
Hepatitis C
1
1996
80
0.010
 Why?
HLA Antigens
1
1992
55
0.010
 Why?
Immunity, Cellular
1
1991
64
0.010
 Why?
Uretsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (614) concept(s)
_
Co-Authors Expand Description
See all (10) people
_
Similar People Expand Description
See all (23) people
_
Same Department Expand Description
Search Department